Heavily Pretreated Patients With Relapsed/Refractory Myeloma Achieve Encouraging Responses With Teclistamab Plus Daratumumab
An expert with the phase 1b TRIMM-2 trial underscores the significance and findings for patients with multiple myeloma.
Oncology Nurses Play Pivotal Role in Survivor Follow-Up Care
Michelle Mollica, PhD, MPH, RN, OCN, senior advisor in the NCI Office of Cancer Survivorship, discusses different long-term care considerations for nurses caring for patients with cancer.
Niraparib, Abiraterone, and Prednisone Triplet Shows Efficacy, Safety in mCRPC With HRR Gene Alterations
The combination of PARP inhibition and androgen receptor targeted therapy was found to be tolerable in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations.
Brianna Lutz on How to Improve Nurse Responsiveness on an Inpatient Oncology Unit
Brianna Lutz, MSN, RN, OCN, discusses a red-and-green dot hourly column that shows which patients with cancer have been attended to in the past hour.
ANA Releases New Survey Findings on Nurse Positions on Medical Aid in Dying
Liz Stokes, PhD, JD, RN, director of the Center for Ethics and Human Rights, discusses the nurse’s role in medical aid in dying and common misconceptions.
Patients With Advanced Prostate Cancer on Relugolix Experience Manageable Toxicity Levels
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, demonstrated a manageable toxicity profile for patients with advanced prostate cancer.
Patricia Jakel Comments on Combating Burnout in the Acute Care Setting
Patricia Jakel, RN, MN, AOCN, discusses burnout and compassion fatigue in acute oncology care.
Patients With Metastatic Urothelial Carcinoma Achieve Superior Survival After Experiencing irAEs With Pembrolizumab
In patients receiving immune checkpoint inhibition to treat their metastatic urothelial carcinoma, immune-related adverse effects may serve as a prognostic marker for progression-free and overall survival.
Regardless of Prior Local Treatment, Patients With mHSPC Achieve Improved Long-Term Survival With Enzalutamide Plus ADT
A post-hoc analysis of the phase 3 ARCHES found enzalutamide plus androgen deprivation therapy to be an effective treatment for patients with metastatic hormone-sensitive prostate cancer, no matter their history of prior local therapy.
Vitamin C Increases Chemotherapy Responses in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer
Patients with locally advanced muscle invasive bladder cancer may experience superior benefit from gemcitabine and carboplatin if the chemotherapy is co-administered with vitamin c.
Loyda Braithwaite Discusses Evolving Treatment Options in HR+ Breast Cancer
Loyda E. Braithwaite, MSN, RN, AGPCNP-BC, AOCNP, highlights nursing considerations in prescribing and administering endocrine therapy to patients with HR+ breast cancer.
Entrectinib Generates Favorable Outcomes in NTRK Fusion+ Breast Cancer
Entrectinib elicited encouraging responses in patients with breast cancer that harbors NTRK fusions, according to updates from the phase 2 STARTRK-2 trial.
Cabozantinib/Nivolumab Showcases Clinical Benefit in Papillary Non–Clear Cell RCC
Phase 2 trial findings indicate that cabozantinib plus nivolumab may be effective in treating patients with non-clear cell renal cell carcinoma with papillary histology.
Investigational RNA Interference Therapy, ARO-HIF2, Yields Encouraging Phase 1 Results in Clear Cell RCC
Patients with clear cell renal cell carcinoma experienced reduced levels of hypoxia inducible factor-2 alpha expression following treatment with ARO-HIF2.
How To Approach Fertility Conversations With AYA Patients as an Oncology Nurse
Conversations surrounding fertility preservation may differ between young men and women with cancer, according to Donna Herrera Bell, MSN, APRN, FNP-C.
Kate Sandstrom on Ensuring Patient Follow-Up With Radiation Oncology Teams
Kate Sandstrom, MSN, APRN-BC, AOCN, discusses the importance of including the radiation oncology team in a patient’s long-term care plan.
Oncology Nurses Drastically Reduce Central Line Infection Incidences Through Peer-to-Peer Observation Strategy
Oncology nurses at the 2022 ASTCT Meeting shared how a peer-to-peer observation and validation tool helped decrease central line-associated bloodstream infections by 68%.
Study Seeks to Identify Connection Between Cognitive function and Anxiety In Patients Receiving Chemotherapy
Unrelieved stress may contribute to cancer-related cognitive impairment and anxiety in patients undergoing chemotherapy.
Established Downtime Procedures Protect Patient Outcomes Against Cyber Attacks
In the age of cyberattacks, establishing and practicing a downtime procedure is crucial to safeguard patient care, according to Kelli-Ann Mancini, MSN, RN, OCN.
Trastuzumab Deruxtecan Continues to Elicit Responses in HER2+ Breast Cancer With Active Brain Metastases
Patients with HER2-positive breast cancer who also have brain metastases experienced clinical benefit with fam-trastuzumab deruxtecan-nxki in the phase 2 TUEXEDO-trial.
Following ADT, Older Patients With Prostate Cancer Are at an Increased Risk of Cardiac Complications
Older men who have received androgen-deprivation therapy are an increased risk of heart issues, however, the root of the risk is still not well understood.
Cancer Survivors Struggling With Insomnia May Benefit from Cognitive Therapy
Cognitive therapies were found to be effective for helping cancer survivors with insomnia, but more research is needed for patients actively receiving treatment.
Patient Wait Times Reduced by Teaching Oncology Nurses to Insert Ultrasound-Guided Peripheral IV
Oncology nurses may be able decrease peripheral access wait times for patients, however, a change in culture may be necessary to see full results.
Jessica MacIntyre on Utilizing Nurse Navigators to Connect Patients to Nutrition Services
Jessica MacIntyre, ARNP, NP-C, AOCNP, discusses empowering oncology nurse navigators to refer patients undergoing chemotherapy or radiation therapy to nutrition services.
Single Nucleotide Polymorphism Genotyping Could Predict Severe Radiation Dermatitis in Breast Cancer
Single nucleotide polymorphism (SNP) genotyping could be used to predict radiation dermatitis in patients with breast cancer.
FDA Approves Trastuzumab Deruxtecan for Unresectable or Metastatic HER2+ Breast Cancer
Fam-trastuzumab deruxtecan-nxki is now an FDA-approved regimen for the treatment of patients with unresectable or metastatic HER2-positive breast cancer.
Standardizing Venous Port Competency Among Non-Oncology Nurses Helps Reduce Delay Times for Patients with Cancer
Increasing the number of intravenous port nurse champions across a health care system helps to keep oncology nurses with their patients and reduce care delays.
FDA Launches Priority Review of Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
The FDA has granted a priority review designation to darolutamide plus docetaxel for patients with metastatic hormone-sensitive prostate cancer.
Incorporating a Death Doula into the Oncology Care Team
The death doula is a unique role that can help oncology care teams improve the quality of end-of-life care delivered to patients.
The Power of Knowledge: Implementing “Pre-” and “Post-Teach” Sessions into a Cancer Treatment Plan
Two oncology nurses with Allegheny Health Network discuss how they guide patients through their diagnosis, treatment, and life after cancer.
Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care
Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC
Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs
Safety Management With Amivantamab Plus Lazertinib in NSCLC
